What Does Encompass Health's (EHC) Upbeat Revenue Guidance Reveal About Its Long-Term Growth Trajectory?

Simply Wall St.11-04

Encompass Health recently reported third-quarter 2025 results showing higher sales of US$1.48 billion and net income of US$126.5 million, alongside raising its 2025 net operating revenue guidance to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2580787990?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","is_english":true,"pubTime":"2025-11-04 15:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580787990","market":"us","top_or_hot":-1,"title":"What Does Encompass Health's (EHC) Upbeat Revenue Guidance Reveal About Its Long-Term Growth Trajectory?","media":"Simply Wall St.","content":"<div>\n<p>Encompass Health recently reported third-quarter 2025 results showing higher sales of US$1.48 billion and net income of US$126.5 million, alongside raising its 2025 net operating revenue guidance to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ehc/encompass-health/news/what-does-encompass-healths-ehc-upbeat-revenue-guidance-reve\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Does Encompass Health's (EHC) Upbeat Revenue Guidance Reveal About Its Long-Term Growth Trajectory?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Does Encompass Health's (EHC) Upbeat Revenue Guidance Reveal About Its Long-Term Growth Trajectory?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-04 15:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-ehc/encompass-health/news/what-does-encompass-healths-ehc-upbeat-revenue-guidance-reve><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Encompass Health recently reported third-quarter 2025 results showing higher sales of US$1.48 billion and net income of US$126.5 million, alongside raising its 2025 net operating revenue guidance to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-ehc/encompass-health/news/what-does-encompass-healths-ehc-upbeat-revenue-guidance-reve\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EHC","symbol_name":"Encompass Health Corporation","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ehc/encompass-health/news/what-does-encompass-healths-ehc-upbeat-revenue-guidance-reve","article_id":"2580787990","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ehc/encompass-health/news/what-does-encompass-healths-ehc-upbeat-revenue-guidance-reve","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2580787990","pubTimestamp":1762240719,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Encompass Health recently reported third-quarter 2025 results showing higher sales of US$1.48 billion and net income of US$126.5 million, alongside raising its 2025 net operating revenue guidance to between US$5.91 billion and US$5.96 billion.\nThis upward guidance, combined with expanding operations and ongoing share repurchases, highlights the company's focus on growth and returning value to shareholders.\nWe'll explore how the raised 2025 revenue guidance signals confidence in underlying...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"EHC":"Encompass Health Corporation"},"translate_title":"Encompass Health(EHC)乐观的收入指引揭示了其长期增长轨迹的哪些方面？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EHC":1.5},"content_text":"Encompass Health recently reported third-quarter 2025 results showing higher sales of US$1.48 billion and net income of US$126.5 million, alongside raising its 2025 net operating revenue guidance to between US$5.91 billion and US$5.96 billion. This upward guidance, combined with expanding operations and ongoing share repurchases, highlights the company's focus on growth and returning value to shareholders. We'll explore how the raised 2025 revenue guidance signals confidence in underlying business momentum and affects Encompass Health's investment outlook. These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.AdvertisementEncompass Health Investment Narrative RecapTo be a shareholder in Encompass Health, you need to believe in the company's ability to capitalize on the growing demand for inpatient rehabilitation, supported by demographic trends and a robust facility expansion pipeline. The recent upward revision of 2025 revenue guidance underscores management’s confidence in business momentum but does not materially change the most important short-term catalyst: ongoing new hospital openings. The biggest risk remains labor market pressures and potential wage inflation, which could threaten operating margins if hiring challenges persist. Among the recent news, Encompass Health’s opening of its 25th rehabilitation hospital in Florida stands out. The addition of this large, advanced facility further supports the company's strategy to expand and capture unmet demand, reinforcing the importance of bed expansion as a key catalyst in the context of the newly raised revenue outlook. However, in contrast to ongoing growth, investors should be aware of unresolved headwinds tied to labor shortages and their possible effects on future margin performance… Read the full narrative on Encompass Health (it's free!)Encompass Health's narrative projects $7.2 billion revenue and $711.6 million earnings by 2028. This requires 8.1% yearly revenue growth and a $189.2 million earnings increase from $522.4 million today.Uncover how Encompass Health's forecasts yield a $139.08 fair value, a 20% upside to its current price.Exploring Other PerspectivesEHC Earnings & Revenue Growth as at Nov 2025 Two fair value estimates from the Simply Wall St Community put Encompass Health's worth in a narrow range between US$139.08 and US$140.33. As you weigh these perspectives, keep in mind that continued new hospital openings and rising demand are central to shaping the company’s next chapter.Explore 2 other fair value estimates on Encompass Health - why the stock might be worth as much as 21% more than the current price!Build Your Own Encompass Health NarrativeDisagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.A great starting point for your Encompass Health research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.Our free Encompass Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Encompass Health's overall financial health at a glance.Curious About Other Options?Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:Uncover the next big thing with financially sound penny stocks that balance risk and reward.The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Encompass Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2580787990","isCrawlerRequest":true}